Evaluation of the efficacy and safety on allergic conjunctivitis of 0.001% Hydrocortisone-0.2% Hyaluronic Acid ophthalmic solution

被引：0

作者：

Allegri, P. ^{[1
]}

Rissotto, R. ^{[2
]}

Rissotto, F. ^{[3
]}

Bergamino, L. ^{[4
]}

Ciurlo, C. ^{[1
]}

机构：

[1] Rapallo Genova Hosp, Dept Ophthalmol, Genoa, Italy

[2] Univ Cattolica Sacro Cuore, Rome, Italy

[3] Univ Genoa, Genoa, Italy

[4] Lavagna Genova Hosp, Pediat Allergol Dept, Genoa, Italy

来源：

ALLERGY | 2020年 / 75卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

0643

引用

页码：325 / 325

页数：1

共 50 条

[41] A comparison of the efficacy and comfort of Alamast (pemirolast potassium 0.1% ophthalmic solution) versus Alocril (nedocromil sodium 2 % ophthalmic solution) in seasonal allergic conjunctivitis.
Slugg, AP
Gomes, PJ
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2001, 42 (04) : S910 - S910
[42] A controlled evaluation of the efficacy and safety of loteprednol etabonate in the prophylactic treatment of seasonal allergic conjunctivitis
Dell, SJ
Shulman, DG
Lowry, GM
Howes, J
Berdy, G
Embry, S
Fox, K
Horwitz, B
KuneshPart, K
Laibovitz, R
Levin, J
Lowry, G
Orlando, R
Parks, D
Walters, T
Coultas, S
Hart, K
Crockett, RS
Novack, GD
AMERICAN JOURNAL OF OPHTHALMOLOGY, 1997, 123 (06) : 791 - 797
[43] Comparative analysis of safety and efficacy of Alcaftadine 0.25%, Olopatadine hydrochloride 0.2% and Bepotastine besilate 1.5% in allergic conjunctivitis
Ayyappanavar, Shruti
Sridhar, Sriya
Kumar, Kiran
Jayanthi, C. R.
Gangasagara, Suresh Babu
Rathod, B. L. Sujatha
Preethi, B.
Mittal, Preeti
INDIAN JOURNAL OF OPHTHALMOLOGY, 2021, 69 (02) : 257 - 261
[44] A comparative trial of the safety and efficacy of 0.1 percent pemirolast potassium ophthalmic solution dosed twice or four times a day in patients with seasonal allergic conjunctivitis
Gous, P
Ropo, A
JOURNAL OF OCULAR PHARMACOLOGY AND THERAPEUTICS, 2004, 20 (02) : 139 - 150
[45] Efficacy and safety of 0.2% naproxen ophthalmic solution in reducing postoperative inflammation after cataract surgery
Santocono, M
Russo, S
Russo, P
Di Bella, A
Papa, V
Milazzo, G
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2002, 43 : U76 - U76
[46] Bepotastine besilate 1.5% ophthalmic solution provides better patient-reported relief of nasal symptoms during treatment of allergic conjunctivitis than olopatadine hydrochloride 0.2% ophthalmic solution
McCabe, C. F.
McCabe, S. E.
ALLERGY AND ASTHMA PROCEEDINGS, 2012, 33 (04) : 375 - 375
[47] CLINICAL-EVALUATION OF KETOROLAC TROMETHAMINE 0.5-PERCENT OPHTHALMIC SOLUTION FOR THE TREATMENT OF SEASONAL ALLERGIC CONJUNCTIVITIS
BALLAS, Z
BLUMENTHAL, M
TINKELMAN, DG
KRIZ, R
RUPP, G
SURVEY OF OPHTHALMOLOGY, 1993, 38 : 141 - 148
[48] Dry Eye Para-Inflammation Management: Preclinical and Clinical Evidence on a Novel 0.2% Hyaluronic Acid-Based Tear Substitute with 0.001% Hydrocortisone Sodium Phosphate
Blanco, Anna Rita
Zasa, Giuseppe
JOURNAL OF CLINICAL MEDICINE, 2024, 13 (18)
[49] Efficacy of nedocromil sodium 2% ophthalmic solution in menopausal women with allergic conjunctivitis: Results from a community-based trial
King, BJ
Tauber, J
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2003, 44 : U310 - U310
[50] Evaluation of the efficacy and safety of combinations of hydroquinone, glycolic acid, and hyaluronic acid in the treatment of melasma
Ibrahim, Zeinab A.
Gheida, Shereen F.
El Maghraby, Gamal M.
Farag, Zeinab E.
JOURNAL OF COSMETIC DERMATOLOGY, 2015, 14 (02) : 113 - 123

← 1 2 3 4 5 →